Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products: St. Jude Renal Denervation; Zimmer Shoulder; Respicardia Sleep Apnea Pulse Generator

This article was originally published in The Gray Sheet

Executive Summary

St. Jude’s next-generation EnligHTN renal denervation system earns a CE mark. Respicardia launches First implant pulse generator to treat central sleep apnea. FDA clears Zimmer shoulder system. GeneDX launches BRCA1 and BRCA2 genetic tests not long after Supreme Court overturns Myriad’s monopoly on the tests.

You may also be interested in...



St. Jude Halts U.S. Renal Denervation Trial, Citing Slow Patient Enrollment

Patient-recruitment challenges have led St. Jude to halt a U.S. clinical trial of its EnligHTN renal denervation system. The company says it is working with FDA to design a new trial.

Medtronic Renal Denervation System Provides Durable Blood Pressure Benefits In Longest Trial To Date

The latest results from Medtronic’s SYMPLICITY HTN-2 trial show that patients treated for severe hypertension with the company’s Symplicity radio frequency renal denervation system showed a sustained reduction in blood pressure. The firm also announced the start of a renal denervation trial in patients with moderate hypertension.

Myriad Wields Proprietary Database To Protect Testing Market

Myriad president Mark Capone made it clear that the company will use its proprietary database of genetic variants on the BRCA1 and BRCA2 genes to try and fend off cheaper competition after the BRACAnalysis test’s method patents are expired, or if they are overturned in court.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT032375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel